The data published in Scientific Reports are the first to implicate a role for RASGRP4 mutations in B-cell malignancies. Relapsed/refractory diffuse large B-cell lymphoma (rrDLBCL) is associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback